Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection

BACKGROUND: The aim of this secondary analysis of the TESEO cohort is to identify, early in the course of treatment with tocilizumab, factors associated with the risk of progressing to mechanical ventilation and death and develop a risk score to estimate the risk of this outcome according to patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussini, Cristina, Cozzi-Lepri, Alessandro, Menozzi, Marianna, Meschiari, Marianna, Franceschini, Erica, Milic, Jovana, Brugioni, Lucio, Pietrangelo, Antonello, Girardis, Massimo, Cossarizza, Andrea, Tonelli, Roberto, Clini, Enrico, Massari, Marco, Bartoletti, Michele, Ferrari, Anna, Cattelan, Anna Maria, Zuccalà, Paola, Lichtner, Miriam, Rossotti, Roberto, Girardi, Enrico, Nicastri, Emanuele, Puoti, Massimo, Antinori, Andrea, Viale, Pierluigi, Guaraldi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901750/
https://www.ncbi.nlm.nih.gov/pubmed/33621264
http://dx.doi.org/10.1371/journal.pone.0247275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901750/
https://www.ncbi.nlm.nih.gov/pubmed/33621264
http://dx.doi.org/10.1371/journal.pone.0247275

Ejemplares similares